Marker Therapeutics Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include Advaxis.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. | ||
Founding Date | Founding Date 2018 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations Princeton, US HQ |
Employees | Employees 888% decrease | Employees 3540% decrease |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) 2.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $13k (FY, 2023) |
Net income | Net income ($12.2m) (FY, 2025) | Net income ($48.1m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company